A biochemical abnormality found in muscle from unstressed malignant-hyperpyrexia-susceptible humans

1984 ◽  
Vol 12 (3) ◽  
pp. 357-358 ◽  
Author(s):  
F. R. ELLIS ◽  
P. J. HALSALL ◽  
P. ALLAM ◽  
E. HAY
Keyword(s):  
Malignant Hyperpyrexia ◽  
Biochemical Abnormality

MALIGNANT HYPERPYREXIA

1977 ◽  
Vol 2 (23) ◽  
pp. 757-758 ◽  
Author(s):  
M. A. Denborough
Keyword(s):  
Malignant Hyperpyrexia

MALIGNANT HYPERPYREXIA IN AUSTRALIA AND NEW ZEALAND

1973 ◽  
Vol 1 (11) ◽  
pp. 525-528 ◽  
Author(s):  
J. O. KING ◽  
M. A. DENBOROUGH
Keyword(s):  
New Zealand ◽  
Malignant Hyperpyrexia

MALIGNANT HYPERPYREXIA

1972 ◽  
Vol 16 (5) ◽  
pp. 433
Author(s):  
K. KYEI-MENSAH ◽  
R. LOCKWOOD ◽  
J. H. TYRELL ◽  
I. H. WILLETT
Keyword(s):  
Malignant Hyperpyrexia

MALIGNANT HYPERPYREXIA AND ANAESTHESIA

1972 ◽  
Vol 16 (1) ◽  
pp. 33
Author(s):  
P. M. E. DRURY ◽  
A. A. GILBERTSON
Keyword(s):  
Malignant Hyperpyrexia

scholarly journals Malignant hyperpyrexia during anaesthesia for colectomy.

BMJ ◽  
1969 ◽  
Vol 1 (5642) ◽  
pp. 488-488 ◽  
Author(s):  
B. R. Murray ◽  
P. A. Williams
Keyword(s):  
Malignant Hyperpyrexia

scholarly journals Hyperthermia syndromes in psychiatry

2009 ◽  
Vol 15 (3) ◽  
pp. 181-191 ◽  
Author(s):  
Niraj Ahuja ◽  
Andrew J. Cole
Keyword(s):  
Drug Treatment ◽  
Neuroleptic Malignant Syndrome ◽  
Electroconvulsive Therapy ◽  
Serotonin Syndrome ◽  
Systematic Approach ◽  
Psychiatric Patients ◽  
Initial Diagnosis ◽  
Malignant Hyperpyrexia ◽  
Malignant Catatonia

SummaryPresence of fever in psychiatric patients may signify a number of potentially fatal conditions. Several of these are related to treatments (e.g. neuroleptic malignant syndrome with antipsychotics, serotonin syndrome with serotonergic antidepressants, and malignant hyperpyrexia with anaesthesia used for administration of electroconvulsive therapy) or exacerbated by them (e.g. malignant catatonia with antipsychotics). New classes of drug treatment may be changing the epidemiology of these disorders. We suggest that an initial diagnosis of hyperthermia syndrome is clinically useful as there are some important commonalities in treatment. We outline a systematic approach to identify a particular subtype of hyperthermia syndrome and the indications for more specific treatments where available.

MENTAL RETARDATION IN A FAMILY WITH PHENYLKETONURIA AND MILD HYPERPH ENYLALANINEMIA

PEDIATRICS ◽  
1969 ◽  
Vol 44 (5) ◽  
pp. 655-660
Author(s):  
Bernard E. Cohen ◽  
Arieh Szeinberg ◽  
Wifred Berman ◽  
Yermiahu Aviad ◽  
Moshe Crispin ◽  
...  
Keyword(s):  
Mental Retardation ◽  
Mentally Retarded ◽  
Biochemical Abnormality ◽  
Maternal Uncle ◽  
The Family ◽  
Phenylalanine Metabolism ◽  
Inbred Family

A highly inbred family with five mentally retarded persons is described. Two sibs presented typical characteristics of phenylketonuria, while one mentally retarded sib did not show any biochemical abnormality. The mother and maternal uncle had mild hyperphenylalaninemia. It is pointed out in the discussion that, while the mental retardation (at least in some of these subjects) may be independent of disturbances of phenylalanine metabolism, it is possible also to explain all the findings in the family on a unified basis, involving a variant hyperphenylalaninemia with tolerance increasing with age and "maternal phenylketonuia."

A Therapeutic Trial of Fatty Acid Supplementation in Cystic Fibrosis

PEDIATRICS ◽  
1976 ◽  
Vol 57 (4) ◽  
pp. 474-479
Author(s):  
Robert B. Elliott
Keyword(s):  
Cystic Fibrosis ◽  
Fatty Acid ◽  
Clinical Course ◽  
Therapeutic Trial ◽  
Biochemical Abnormality ◽  
Fatty Acid Supplementation ◽  
Oil Emulsion ◽  
Soya Oil ◽  
One Year ◽  
Better Than

Seven children with cystic fibrosis (CF) have been treated for at least one year with intravenously administered soya oil emulsion. In all, an improvement of at least one biochemical abnormality in character with the disease appeared. The children's clinical course remains benign. This course is remarkably better than that of other children with CF treated without Intralipid in Auckland in the same period, though a placebo effect cannot be discounted. It is postulated that intravenous supplementation with essential fatty acid in CF may in turn partially correct an error of metabolism of prostaglandins present in the disease.

AN UNUSUAL CASE OF MALIGNANT HYPERPYREXIA

1976 ◽  
Vol 20 (3) ◽  
pp. 246???247
Author(s):  
B. Peltz ◽  
J. Carstens
Keyword(s):  
Unusual Case ◽  
Malignant Hyperpyrexia
Sign in / Sign up

Export Citation Format

Share Document